Abstracts tagged "Randomized trials and statistical methods"

Abstract Number: 1410 • 2018 ACR/ARHP Annual Meeting
Assessment of Work Outcomes with Truncation from Job Loss in an Arthritis Randomized Clinical Trial
Michael P. LaValley¹, Carrie Brown^1,2, David T. Felson^3,4 and Julie Keysor⁵, ¹Biostatistics, Boston University School of Public Health, Boston, MA, ²The Emmes Corporation, Rockville, MD, ³ARC Epidemiology Unit, University of Manchester, Manchester, MA, ⁴Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ⁵Physical Therapy, MGH Institute of Health Professions, Boston, MA
Background/Purpose: Methods for causal analysis in randomized clinical trials (RCT) where functional outcomes may be truncated by death of participants have been developed but are…
Abstract Number: 2874 • 2018 ACR/ARHP Annual Meeting
Comparison of Missing Data Reporting and Handling in Randomized Controlled Trials of Rheumatoid Arthritis Drug Therapy: A Snapshot Ten Years Apart
Fawad Aslam¹, Karina Torralba² and Nasim A. Khan³, ¹Rheumatology, Mayo Clinic, Scottsdale, AZ, ²University of Southern California, LA, CA, ³Rheumatology, Univ of Arkansas for Med Sci, Little Rock, AR
Background/Purpose: Intention-to-treat (ITT) principle is recommended to analyze randomized controlled trials (RCTs). It entails analyzing all subjects per the assigned group at randomization to avoid…
Abstract Number: 1452 • 2017 ACR/ARHP Annual Meeting
Handling of Missing Data, Protocol Violation and Performance of Intention-to-Treat Analysis in the Randomized Controlled Trials of Drug Therapy of Rheumatoid Arthritis
Fawad Aslam¹, Karina Torralba² and Nasim A. Khan³, ¹Rheumatology, Mayo Clinic, Scottsdale, AZ, ²Division of Rheumatology, Department of Internal Medicine, Loma Linda University, Loma Linda, CA, ³Rheumatology, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR
Background/Purpose: Intention-to-treat (ITT) method is recommended to analyze Randomized Controlled Trials (RCTs). It requires analyzing all participants per the assigned intervention group at randomization to…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].